课题基金 / 基金详情

Monoterpenoid indole alkaloid biosynthesis

Monoterpenoid indole alkaloid biosynthesis
单萜吲哚生物碱生物合成
批准号:
RGPIN-2017-04145
负责人:
DeLuca, Vincenzo
金额:
$5.03万
依托单位:
依托单位国家:
加拿大
项目类别:
Discovery Grants Program - Individual
财政年份:
2022
资助国家:
加拿大
项目状态:
已结题
起止时间:
2022-01-01 至 2023-12-31

项目摘要

项目成果

DeLuca, Vincenzo的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Plantshave remarkable attributes for being able to perform complex and biologicallyinnovative biochemistry that generates a diversity of colors, fragrances, aromasand biologically active organic molecules. While the majority of the molecules produced arenot directly essential for survival, many may play key roles in plantadaptation to the biotic and abiotic environment. The unique biologicalactivities of this chemical diversity have provided medicinal and diseasepreventing molecules that have been used by humanity to prevent/cure manydevastating diseases. The monoterpenoid indole alkaloids (MIAs) makeup the largest and most diverse class of compounds that are characteristicallyfound within many members of the Apocynaceae (4700 species), the Loganiaceae(600 species) and the Rubiaceae (> 10,000 species) plant families. Thecomplexity of MIA chemistry is matched by their remarkably diverse effects onliving organisms that has led to their use as drugs for preventing malaria(quinine) and for treating neurological disorders (reserpine), cancer(camptothecin, vinblastine and vincristine), as vasodilators (yohimbine), asanti-inflammatories for gout treatments (colchicine) and as potential analgesics and novel painkillers (conolidine) in human beings. Over the past >25 years my laboratoryhas made many key discoveries about the biosynthesis ofanti-cancer MIAs of the Madagascar periwinkle (Catharanthus roseus) that have been used in chemotherapy treatmentsover the past 45 years. The genetic resources and biochemical knowledge derived from these discoveries arepresently being exploited to enhance the production of valuable medicinalcompounds in C. roseus or through synthetic biology experiments in other organisms including yeast or in microbialfactories. The production of MIA pharmaceuticals in recombinant organismscreates unique opportunities for less expensive manufacturing of existing MIA drugsand for generating new and unique medicines not available from natural sources. The initial discoveries made in this model plant have also greatly improved the tools available for gene discovery of other MIA pathways found in Nature and for learning about the ecological roles that MIAs play in plant fitness and adaptations to their environment.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Plant Biotechnology
  • 批准号:
    CRC-2015-00294
  • 项目类别:
    Canada Research Chairs
  • 资助金额:
    $7.29万
  • 财政年份:
    2022
  • 负责人:
    DeLuca, Vincenzo
  • 依托单位:
Plant Biotechnology
  • 批准号:
    CRC-2015-00294
  • 项目类别:
    Canada Research Chairs
  • 资助金额:
    $14.57万
  • 财政年份:
    2021
  • 负责人:
    DeLuca, Vincenzo
  • 依托单位:
Monoterpenoid indole alkaloid biosynthesis
  • 批准号:
    RGPIN-2017-04145
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $5.03万
  • 财政年份:
    2021
  • 负责人:
    DeLuca, Vincenzo
  • 依托单位:
Plant Biotechnology
  • 批准号:
    CRC-2015-00294
  • 项目类别:
    Canada Research Chairs
  • 资助金额:
    $14.57万
  • 财政年份:
    2020
  • 负责人:
    DeLuca, Vincenzo
  • 依托单位:
国内基金
海外基金
miRNA在3,3'-二吲哚甲烷诱导肝肿瘤细胞凋亡的作用研究
  • 批准号:
    81101562
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    22.0万元
  • 批准年份:
    2011
  • 负责人:
    朱伟
  • 依托单位: